Phenomex Stock Fundamentals
| CELLDelisted Stock | 0.60 0.00 0.00% |
PhenomeX fundamentals help investors to digest information that contributes to PhenomeX's financial success or failures. It also enables traders to predict the movement of PhenomeX Stock. The fundamental analysis module provides a way to measure PhenomeX's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PhenomeX stock.
PhenomeX |
PhenomeX Company Net Income Analysis
PhenomeX's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current PhenomeX Net Income | (98.04 M) |
Most of PhenomeX's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PhenomeX is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, PhenomeX reported net income of (98.04 Million). This is 128.73% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 117.17% higher than that of the company.
PhenomeX Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining PhenomeX's current stock value. Our valuation model uses many indicators to compare PhenomeX value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PhenomeX competition to find correlations between indicators driving PhenomeX's intrinsic value. More Info.PhenomeX is number one stock in price to earning category among its peers. It also is the top company in revenue category among its peers totaling about 3,479,194 of Revenue per Price To Earning. Comparative valuation analysis is a catch-all technique that is used if you cannot value PhenomeX by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.PhenomeX Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PhenomeX's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PhenomeX could also be used in its relative valuation, which is a method of valuing PhenomeX by comparing valuation metrics of similar companies.PhenomeX is currently under evaluation in net income category among its peers.
PhenomeX Fundamentals
| Price To Earning | 22.59 X | |||
| Revenue | 78.59 M | |||
| EBITDA | (97.03 M) | |||
| Net Income | (98.04 M) | |||
| Cash And Equivalents | 30.05 M | |||
| Cash Per Share | 0.43 X | |||
| Total Debt | 4.97 M | |||
| Debt To Equity | 0.66 % | |||
| Current Ratio | 1.17 X | |||
| Cash Flow From Operations | (47.54 M) | |||
| Earnings Per Share | 0.40 X | |||
| Price To Earnings To Growth | 1.08 X | |||
| Number Of Employees | 285 | |||
| Beta | 1.54 | |||
| Market Capitalization | 620.37 M | |||
| Total Asset | 226.09 M | |||
| Retained Earnings | (361.65 M) | |||
| Working Capital | 131.46 M | |||
| Current Asset | 971.71 M | |||
| Current Liabilities | 831.17 M | |||
| Z Score | 72.34 | |||
| Net Asset | 226.09 M |
About PhenomeX Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PhenomeX's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PhenomeX using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PhenomeX based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Brightpoint, Inc. offer device lifecycle services to the wireless and hightech industries.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in PhenomeX Stock
If you are still planning to invest in PhenomeX check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PhenomeX's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |